Abbott Laboratories (NYSE:ABT) was on track to snap six consecutive sessions of gains as the stock dropped 2.29% to $131.21 during Monday’s afternoon trading.
The drugmaker gained 5.49% in the previous six sessions. On a YTD basis, Abbott has risen by more than